ICCC — IMMUCELL CORP /DE/
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 811641 ·
Last close
$9.88
Market Cap
$89.73M
52W High
$12.10
52W Low
$4.52
ADV30
21,342
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 7,186,113 | 2,437,222 | 1,934,934 | 1,834,656 | 46,629,796 | 8,860,205 | 15,255,260 |
| Mar 2026 | 10,357,295 | 4,657,444 | 1,969,316 | 1,941,607 | 44,108,374 | 6,812,637 | 14,973,334 |
| Dec 2025 | 7,625,999 | 2,910,209 | -57,956 | -2,849,142 | 42,532,447 | 3,806,831 | 15,476,967 |
| Sep 2025 | 5,506,122 | 2,363,098 | 20,075 | -139,748 | 45,730,123 | 3,886,198 | 15,929,282 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$4,474,487
Investing CF
$-1,052,487
Financing CF
$-1,208,734
CapEx
$-1,098,619
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.06
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-13,262,146
Inventory
$8,673,752
Receivables
$2,728,145
ST Investments
—
EBIT TTM
$-93,977
Pretax Income TTM
$-523,215
Interest Exp TTM
$429,238
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$30,675,528
EBITDA
$7,050,686
Free Cash Flow
$3,082,192
Enterprise Value
$93,046,968
Total Cash
$8,860,205
Total Debt
$12,447,535
Shares Out
9,082,197
Trailing EPS
$0.07
Book Value
$3.46
ROE
2.6%
ROA
6.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 27,644,174 | 1,649,305 | -1,040,027 | 42,532,447 | 15,476,967 | 27,055,480 | 2,475,292 |
| Dec 2024 | 26,493,169 | -1,640,159 | -2,156,629 | 45,100,477 | 17,582,290 | 27,518,187 | 357,903 |
| Dec 2023 | 17,471,669 | -5,748,078 | -5,774,598 | 43,808,102 | 18,815,025 | 24,993,077 | -4,674,236 |
| Dec 2022 | 18,567,962 | -2,298,943 | -2,493,805 | 44,860,649 | 14,480,600 | 30,380,049 | -1,543,871 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.11
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IMDX | Insight Molecular Diagnostics Inc. | $104.06M | $3.18 | — |
| MXCT | MAXCYTE, INC. | $119.72M | $1.16 | — |
| IBAC | IB Acquisition Corp. | $56.59M | $11.30 | — |
| ONMD | OneMedNet Corp | $37.53M | $0.63 | — |
| NNNN | Anbio Biotechnology | $267.30M | $6.09 | — |
News headlines (Yahoo Finance, 1h cache)
ImmuCell (ICCC) Q2 2026 Earnings Call Transcript
2026-08-20 22:45 · Yahoo
ImmuCell Corp (ICCC) (Q2 2026) Earnings Call Highlights: Record Net Income and Market Share ...
2026-08-14 23:01 · Yahoo
ImmuCell Q2 Earnings Call Highlights
2026-08-14 14:04 · Yahoo
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2026
2026-08-13 20:05 · Yahoo
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2026
2026-08-06 20:05 · Yahoo
ImmuCell Posts Strong Preliminary Q2 Sales on U.S. Demand
2026-07-10 13:45 · Yahoo
ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results
2026-07-09 20:05 · Yahoo
ICCC's Valuation Remains Premium: Is it Worth Overpaying for?
2026-06-18 14:26 · Yahoo
ImmuCell Q1 Earnings Rise Y/Y as Sales Climb on Strong Demand
2026-05-25 13:45 · Yahoo
ImmuCell Corp (ICCC) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic Growth
2026-05-15 23:01 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.